Caplin Point's US injectable growth triples, boosting Q1 revenue by 20%

Indian pharmaceutical firm Caplin Point reports a 20% rise in first-quarter revenue, driven by a tripling of its US injectable business and strategic expansion plans amid a strong balance sheet. Caplin Point Laboratories said its first-quarter revenue rose 20% year…













